Details for New Drug Application (NDA): 060574
✉ Email this page to a colleague
NDA 060574 describes MYCOSTATIN, which is a drug marketed by Delcor Asset Corp and is included in seven NDAs. Additional details are available on the MYCOSTATIN profile page.
The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 060574
| Tradename: | MYCOSTATIN |
| Applicant: | Delcor Asset Corp |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060574
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500,000 UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
